We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$333M
Cap. Flow %
-8.21%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CC icon
501
Chemours
CC
$2.7B
$1.57M 0.04%
92,742
+5,413
+6% +$105K
ORCL icon
502
CALL
Oracle
ORCL
$420B
$1.57M 0.04%
+9,400
New +$1.67M
CDW icon
503
CALL
CDW
CDW
$19.7B
$1.57M 0.04%
9,000
-9,700
-52% -$1.88M
CEG icon
504
Constellation Energy
CEG
$95.4B
$1.57M 0.04%
6,998
-4,282
-38% -$1.07M
ITCI
505
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.56M 0.04%
+18,700
New +$1.54M
BYND icon
506
PUT
Beyond Meat
BYND
$327M
$1.55M 0.04%
411,800
-3,800
-0.9% -$20.2K
ABEO icon
507
Abeona Therapeutics
ABEO
$389M
$1.55M 0.04%
277,585
+56,048
+25% +$345K
CLDX icon
508
PUT
Celldex Therapeutics
CLDX
$3.07B
$1.54M 0.04%
60,900
-29,300
-32% -$796K
CTAS icon
509
CALL
Cintas
CTAS
$81.5B
$1.53M 0.04%
8,400
+6,200
+282% +$1.3M
VIR icon
510
CALL
Vir Biotechnology
VIR
$1.55B
$1.52M 0.04%
+207,700
New +$1.64M
LNT icon
511
Alliant Energy
LNT
$18.3B
$1.51M 0.04%
+25,502
New +$1.54M
FVRR icon
512
Fiverr
FVRR
$347M
$1.5M 0.04%
47,308
+10,950
+30% +$318K
CTSH icon
513
CALL
Cognizant
CTSH
$25.3B
$1.5M 0.04%
+19,500
New +$1.53M
BMY icon
514
Bristol-Myers Squibb
BMY
$135B
$1.5M 0.04%
+26,437
New +$1.48M
NEWT icon
515
NewtekOne
NEWT
$445M
$1.49M 0.04%
116,892
+7,389
+7% +$100K
DVN icon
516
Devon Energy
DVN
$50.8B
$1.49M 0.04%
+45,574
New +$1.72M
EXPE icon
517
Expedia Group
EXPE
$37.5B
$1.49M 0.04%
8,004
-6,821
-46% -$1.18M
MXF
518
Mexico Fund
MXF
$312M
$1.49M 0.04%
+112,864
New +$1.59M
NAMS icon
519
CALL
NewAmsterdam Pharma
NAMS
$3.22B
$1.48M 0.04%
+57,600
New +$1.22M
NAMS icon
520
PUT
NewAmsterdam Pharma
NAMS
$3.22B
$1.48M 0.04%
+57,600
New +$1.22M
TREE icon
521
LendingTree
TREE
$474M
$1.48M 0.04%
38,109
-8,396
-18% -$402K
RDW.WS
522
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
$1.47M 0.04%
89,188
+17,698
+25% +$57.7K
ZUO
523
DELISTED
Zuora, Inc.
ZUO
$1.47M 0.04%
147,783
-209,814
-59% -$2.04M
KVUE icon
524
Kenvue
KVUE
$37.5B
$1.46M 0.04%
68,618
-19,919
-22% -$452K
TPG icon
525
TPG
TPG
$7.86B
$1.46M 0.04%
23,268
-1,865
-7% -$123K

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $333M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.